| Pharmaceutical active ingredients: |
| Amitriptyline HydrochloridePerphenazine |
| Available forms, composition and doses of Mutabon D: |
| Tablets; Oral; Amitriptyline Hydrochloride 25 mg; Perphenazine 2 mg |
| Mutabon D medical category: |
| Human:PhenothiazinesTricyclics and other norepinephrine-reuptake inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06CA01 - Amitriptyline and psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schering-PloughEssex |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Musvan | Ambroxol | Parggon Laboratorios |
| Musxan | Methocarbamol | Pharmasant Laboratories; Central Poly Trading |
| Mutabase | Amitriptyline Hydrochloride; Perphenazine | Schering-Plough |
| Mutabon | Amitriptyline Hydrochloride; Perphenazine | Schering-Plough |
| Mutabon A / D / F | Amitriptyline Hydrochloride; Perphenazine | Schering-Plough |
| Mutabon M | Amitriptyline; Perphenazine | Schering-Plough |
| Mutacol | Cholera Vaccine Oral live CVD 103-HGR | Berna |
| Mutaflor | Escherichia Coli | Ardeypharm; Emonta Pharma; Medipharm, Chile |
| Mutaflor Mite | Escherichia Coli | Ardeypharm; Emonta Pharma; Medipharm, Chile |
| Mutagen | Mechlorethamine | Unidentified Pharmaceutical Company |